PathAI, a company that provides AI-powered technology for advancing pathology research, announced on Tuesday that it has named Pathologist and executive leader Eric Walk, MD, FCAP, as its new chief medical officer.
In the new role, Dr Walk is to manage Clinical, Regulatory, Medical Affairs and Pathology teams.
Dr Walk has held the position of chief medical & scientific officer and SVP of Medical and Scientific Affairs at Roche Tissue Diagnostics (Ventana Medical Systems). He was a member of the Roche Medical Leadership Team establishing the global medical strategy for the Diagnostics division. He has worked at Novartis Oncology in Translational Medicine and Early Clinical Development.
Bioforum, The Data Masters names new President
VolitionRx names new Chief Medical Officer
Quotient Sciences announces new appointments
Syndax Pharmaceuticals names new chief commercial officer
Everest Medicines names new chief medical officer and chief product officer
D3 Bio names new independent board member
Rigel Pharmaceuticals names new executive vice president and chief medical officer
Telix Pharmaceuticals names new group chief operating officer